The LAMA Trial: Laparoscopic Correction of Perforated Peptic Ulcer Versus Open Correction
NCT ID: NCT00745667
Last Updated: 2008-09-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
109 participants
INTERVENTIONAL
1999-07-31
2007-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
laparoscopic
laparoscopic surgery
laparoscopic correction perforated peptic ulcer
2
open correction
Upper laparotomy
upper laparotomy for correction of perforated peptic ulcer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
laparoscopic surgery
laparoscopic correction perforated peptic ulcer
Upper laparotomy
upper laparotomy for correction of perforated peptic ulcer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Younger than 18 years
* Unable to sign consent form
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gastrostart
OTHER
Erasme University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diaconessenhuis
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johan Lange, PhD,MD
Role: STUDY_DIRECTOR
Erasmus university hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Diaconessenhuis
Leiden, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Gastrostart The Netherlands
Identifier Type: -
Identifier Source: secondary_id
LAMA1
Identifier Type: -
Identifier Source: org_study_id